Petros Pharmaceuticals announces its partnership with Idea Evolver. The partnership will focus on developing an application to help facilitate the technology element for the Company’s prescription to OTC switch for its erectile dysfunction drug STENDRA. The application will be developed using IE’s proprietary Rx-to-OTC platform, CodeScripts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PTPI: